Clinical Trial Update: FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma [Phase 1]

View source ↗

Summary

A Phase 1 trial of FL118 for pancreatic ductal adenocarcinoma has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• FL118

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Advanced Pancreatic Ductal Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma | Phase 1 | Status: WITHDRAWN